GLP-1 RA’s Role in the Management of Diabetes: Tools for the Primary Care Professional-Introduction

Video Transcription

Video Summary

Inderpreet Madihar introduces a program focusing on GLP-1 medications for diabetes management, developed by the American Association of Clinical Endocrinologists and the American Association of Nurse Practitioners, with support from Novo Nordisk. GLP-1 agonists, taken weekly, lower A1c and body weight while reducing cardiovascular events and kidney disease progression, with lower hypoglycemia risk compared to insulin. The program emphasizes motivational interviewing, personalized education, and adherence strategies. It also addresses overcoming barriers and improving diabetes management using GLP-1 medications, which enhance cardiovascular health and impact metabolic functions positively.

Keywords

GLP-1 medications

diabetes management

cardiovascular health

motivational interviewing

personalized education